anmelden
OMX Nordic 40
2.604,64
PKT
-12,05
PKT
-0,46
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.09.15 | ABB (Asea Brown Boveri) Neutral | Credit Suisse Group | |
| 10.09.15 | Nokia buy | Goldman Sachs Group Inc. | |
| 10.09.15 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 10.09.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.09.15 | AstraZeneca buy | UBS AG | |
| 10.09.15 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 09.09.15 | Volvo (B) Neutral | UBS AG | |
| 09.09.15 | Nokia buy | UBS AG | |
| 09.09.15 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 07.09.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 07.09.15 | ABB (Asea Brown Boveri) Neutral | Credit Suisse Group | |
| 07.09.15 | AstraZeneca Hold | Deutsche Bank AG | |
| 04.09.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.09.15 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.09.15 | Volvo (B) buy | Citigroup Corp. | |
| 02.09.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.09.15 | AstraZeneca buy | UBS AG | |
| 02.09.15 | AstraZeneca buy | HSBC | |
| 28.08.15 | Volvo (B) buy | HSBC | |
| 27.08.15 | Novo Nordisk overweight | Morgan Stanley | |
| 27.08.15 | Novo Nordisk buy | Citigroup Corp. | |
| 27.08.15 | Volvo (B) Sell | UBS AG | |
| 27.08.15 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 27.08.15 | Novo Nordisk Neutral | UBS AG | |
| 27.08.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 25.08.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 25.08.15 | Novo Nordisk buy | Citigroup Corp. | |
| 21.08.15 | Novo Nordisk buy | Citigroup Corp. | |
| 21.08.15 | AstraZeneca buy | Citigroup Corp. | |
| 21.08.15 | Nokia Halten | Independent Research GmbH | |
| 21.08.15 | ABB (Asea Brown Boveri) buy | HSBC | |
| 21.08.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 21.08.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 19.08.15 | AstraZeneca Underweight | Morgan Stanley | |
| 11.08.15 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.08.15 | Novo Nordisk kaufen | Barclays Capital | |
| 07.08.15 | AstraZeneca buy | Jefferies & Company Inc. | |
| 07.08.15 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 06.08.15 | Novo Nordisk Sell | S&P Capital IQ | |
| 04.08.15 | Novo Nordisk Neutral | BNP PARIBAS |